News

Partex.AI Introduces “Ontosight® Dhanvantari”: India’s Sovereign Healthcare Foundation Model Ecosystem Built Using NVIDIA AI

18 February 2026

Partex.AI Introduces “Ontosight® Dhanvantari”: India’s Sovereign Healthcare Foundation Model Ecosystem Built Using NVIDIA AI

New Delhi, February 18, 2026 — Partex.AI today introduced Ontosight® Dhanvantari, a sovereign healthcare foundation model designed to address India’s unique clinical, linguistic, and population health needs. Built on NVIDIA Nemotron models, initiative aims to develop a multimodal, multilingual, Indic-language AI foundation model tailored for Indian healthcare workflows and datasets. NVIDIA is providing technical guidance and platform support for the development of Ontosight® Dhanvantari.


A key pillar of the initiative is the use of NVIDIA FLARE (NVIDIA Federated Learning Application Runtime Environment) for federated learning, enabling hospitals to collaboratively train AI models while ensuring sensitive patient data remains within their own infrastructure. This privacy-first approach supports compliance with India’s Digital Personal Data Protection (DPDP) Act and Ayushman Bharat Digital Mission (ABDM) guidelines, while addressing long-standing challenges related to data silos and trust in healthcare AI adoption.


The initiative integrates data from hospital HIMS, diagnostics, and on-field data captured via mobile devices into Partex.AI’s Ontosight® AI platform. This enables real-time inferencing, clinical dashboards, and analytics to support doctors, public health teams, and administrators in day-to-day decision-making. Ontosight® Dhanvantari has entered the execution phase with an initial pilot in Maharashtra, spanning one urban and one rural district to validate data flows, clinical usability, and operational readiness across diverse healthcare settings.


“With Ontosight® Dhanvantari, our aim is to make AI practical and usable in Indian hospitals—not as a research prototype, but as a clinical support system that fits naturally into existing workflows,” said Dr. Gunjan Bhardwaj, CEO of Partex.AI.“With support from NVIDIA, we are focusing on realistic use cases such as longitudinal patient views,

population-level risk stratification, and early identification of non-communicable diseases like diabetes and cancer.”


“The evolution of healthcare demands AI that is both tailored to local populations and compliant with strict data privacy mandates,” said Vishal Dhupar, Managing Director, Asia South, NVIDIA India. “Leveraging NVIDIA Nemotron models and FLARE, Partex.AI is building a secure, Indic-language AI foundation for India's clinical workflows.”


About Partex.AI

Partex.AI is an AI-powered therapeutic asset accelerator focused on addressing inefficiencies in drug discovery, development, and healthcare delivery by combining large-scale real-world data with advanced artificial intelligence across life sciences and healthcare systems.


Contact Us :

Amaya Sharma

Marketing Manager, Partex.AI

amaya.sharma@partex.ai

Mobile: 7391099060